2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Breast Neoplasms
6
Pancreatic Neoplasms
4
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thymus Neoplasms
1
Thymoma
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Sarcoma
1
Rectal Neoplasms
1
Pancreatitis
1
Pancreatic Diseases
1
Neoplasms, Germ Cell and Embryonal
1
Mesothelioma
1
Medulloblastoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Epilepsy
1
Ependymoma
1
Interventions
Paclitaxel
10
trametinib
9
dabrafenib
9
pembrolizumab
5
lenvatinib
5
fosbretabulin
4
Sorafenib
4
Radiotherapy, Intensity-Modulated
4
Doxorubicin
4
Radiotherapy
3
Cisplatin
3
pazopanib
2
efatutazone
2
combretastatin
2
cobimetinib
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
Vemurafenib
2
Trastuzumab
2
Taxes
2
Nivolumab
2
Gefitinib
2
Filgrastim
2
Everolimus
2
Docetaxel
2
Carboplatin
2
Bevacizumab
2
zimberelimab
1
vandetanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Carcinoma, Anaplastic
×
Histocompatibility Testing
×
Clear all
NCT01774279
2021-01-05
iNATT
Velindre NHS Trust
Unknown
350 enrolled